Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Multiparametric MRI for prostate cancer diagnosis: current status and future directions.

Stabile A, Giganti F, Rosenkrantz AB, Taneja SS, Villeirs G, Gill IS, Allen C, Emberton M, Moore CM, Kasivisvanathan V.

Nat Rev Urol. 2019 Jul 17. doi: 10.1038/s41585-019-0212-4. [Epub ahead of print] Review.

PMID:
31316185
2.

Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.

Brown LC, Ahmed HU, Faria R, El-Shater Bosaily A, Gabe R, Kaplan RS, Parmar M, Collaco-Moraes Y, Ward K, Hindley RG, Freeman A, Kirkham A, Oldroyd R, Parker C, Bott S, Burns-Cox N, Dudderidge T, Ghei M, Henderson A, Persad R, Rosario DJ, Shergill I, Winkler M, Soares M, Spackman E, Sculpher M, Emberton M.

Health Technol Assess. 2018 Jul;22(39):1-176. doi: 10.3310/hta22390.

3.

Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer.

An JY, Sidana A, Choyke PL, Wood BJ, Pinto PA, Türkbey İB.

Balkan Med J. 2017 Sep 29;34(5):388-396. doi: 10.4274/balkanmedj.2017.0708.

4.

Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer.

Panebianco V, Valerio MC, Giuliani A, Pecoraro M, Ceravolo I, Barchetti G, Catalano C, Padhani AR.

Eur Urol Oncol. 2018 Aug;1(3):208-214. doi: 10.1016/j.euo.2018.03.008. Epub 2018 May 15.

PMID:
31102623
5.

Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.

Mannaerts CK, Gayet M, Verbeek JF, Engelbrecht MRW, Savci-Heijink CD, Jager GJ, Gielens MPM, van der Linden H, Beerlage HP, de Reijke TM, Wijkstra H, Roobol MJ.

Eur Urol Oncol. 2018 Jun;1(2):109-117. doi: 10.1016/j.euo.2018.02.010. Epub 2018 May 15.

PMID:
31100233
6.

The current and future role of magnetic resonance imaging in prostate cancer detection and management.

Radtke JP, Teber D, Hohenfellner M, Hadaschik BA.

Transl Androl Urol. 2015 Jun;4(3):326-41. doi: 10.3978/j.issn.2223-4683.2015.06.05. Review.

7.

Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis.

Willis SR, Ahmed HU, Moore CM, Donaldson I, Emberton M, Miners AH, van der Meulen J.

BMJ Open. 2014 Jun 15;4(6):e004895. doi: 10.1136/bmjopen-2014-004895.

8.

Improved detection and reduced biopsies: the effect of a multiparametric magnetic resonance imaging-based triage prostate cancer pathway in a public teaching hospital.

Donato P, Morton A, Yaxley J, Teloken PE, Coughlin G, Esler R, Dunglison N, Gardiner RA, Roberts MJ.

World J Urol. 2019 May 4. doi: 10.1007/s00345-019-02774-y. [Epub ahead of print]

PMID:
31055625
9.

Magnetic resonance imaging in prostate cancer detection and management: a systematic review.

Monni F, Fontanella P, Grasso A, Wiklund P, Ou YC, Randazzo M, Rocco B, Montanari E, Bianchi G.

Minerva Urol Nefrol. 2017 Dec;69(6):567-578. doi: 10.23736/S0393-2249.17.02819-3. Epub 2017 May 8. Review.

10.

Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia.

Gordon LG, James R, Tuffaha HW, Lowe A, Yaxley J.

J Magn Reson Imaging. 2017 May;45(5):1304-1315. doi: 10.1002/jmri.25504. Epub 2016 Oct 11.

PMID:
27726240
11.

The primacy of multiparametric MRI in men with suspected prostate cancer.

Richenberg J, Løgager V, Panebianco V, Rouviere O, Villeirs G, Schoots IG.

Eur Radiol. 2019 Jun 6. doi: 10.1007/s00330-019-06166-z. [Epub ahead of print] Review.

PMID:
31172275
12.

A prospective study investigating the impact of multiparametric MRI in biopsy-naïve patients with clinically suspected prostate cancer: The PROKOMB study.

Baur ADJ, Henkel T, Johannsen M, Speck T, Weißbach L, Hamm B, König F.

Contemp Clin Trials. 2017 May;56:46-51. doi: 10.1016/j.cct.2017.03.001. Epub 2017 Mar 6.

PMID:
28279782
13.

Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy.

Borkowetz A, Platzek I, Toma M, Renner T, Herout R, Baunacke M, Laniado M, Baretton G, Froehner M, Zastrow S, Wirth M.

BJU Int. 2016 Aug;118(2):213-20. doi: 10.1111/bju.13461. Epub 2016 Apr 2.

14.

The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients.

Postema AW, Scheltema MJ, Mannaerts CK, Van Sloun RJ, Idzenga T, Mischi M, Engelbrecht MR, De la Rosette JJ, Wijkstra H.

BMC Urol. 2017 Apr 5;17(1):27. doi: 10.1186/s12894-017-0213-7.

15.

Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature.

Fütterer JJ, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A, Taneja SS, Thoeny H, Villeirs G, Villers A.

Eur Urol. 2015 Dec;68(6):1045-53. doi: 10.1016/j.eururo.2015.01.013. Epub 2015 Feb 2. Review.

PMID:
25656808
16.

The added value of systematic biopsy in men with suspicion of prostate cancer undergoing multiparametric MRI-targeted biopsy.

Mannaerts CK, Kajtazovic A, Lodeizen OAP, Gayet M, Engelbrecht MRW, Jager GJ, Wijkstra H, de Reijke TM, Beerlage HP.

Urol Oncol. 2019 May;37(5):298.e1-298.e9. doi: 10.1016/j.urolonc.2019.01.005. Epub 2019 Jan 17.

PMID:
30660493
17.

Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study.

Washino S, Kobayashi S, Okochi T, Kameda T, Konoshi T, Miyagawa T, Takayama T, Morita T.

BMC Urol. 2018 May 30;18(1):51. doi: 10.1186/s12894-018-0361-4.

18.

Diagnostic Pathway with Multiparametric Magnetic Resonance Imaging Versus Standard Pathway: Results from a Randomized Prospective Study in Biopsy-naïve Patients with Suspected Prostate Cancer.

Porpiglia F, Manfredi M, Mele F, Cossu M, Bollito E, Veltri A, Cirillo S, Regge D, Faletti R, Passera R, Fiori C, De Luca S.

Eur Urol. 2017 Aug;72(2):282-288. doi: 10.1016/j.eururo.2016.08.041. Epub 2016 Aug 27.

PMID:
27574821
19.

Using multiparametric MRI to 'personalize' biopsy for men.

Mendhiratta N, Meng X, Taneja SS.

Curr Opin Urol. 2015 Nov;25(6):498-503. doi: 10.1097/MOU.0000000000000216. Review.

PMID:
26414608
20.

Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla.

Nix JW, Turkbey B, Hoang A, Volkin D, Yerram N, Chua C, Linehan WM, Wood B, Choyke P, Pinto PA.

BJU Int. 2012 Dec;110(11 Pt B):E694-700. doi: 10.1111/j.1464-410X.2012.11503.x. Epub 2012 Oct 4.

Supplemental Content

Support Center